Chemomab Therapeutics Ltd. Shares Authorized
Chemomab Therapeutics Ltd. (CMMB) had Shares Authorized of 4.65 billion shares as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-03-23
- 2025-12-31: Common Stock, Shares Authorized 4.65B shares.
- 2025-06-30: Common Stock, Shares Authorized 4.65B shares.
- 2024-12-31: Common Stock, Shares Authorized 4.65B shares.
- 2024-06-30: Common Stock, Shares Authorized 4.65B shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2025-12-31 | 4.65B shares 20-F · filed 2026-03-23 |
| 2025-06-30 | 4.65B shares 6-K · filed 2025-08-14 |
| 2024-12-31 | 4.65B shares 20-F · filed 2026-03-23 |
| 2024-06-30 | 4.65B shares 6-K · filed 2024-08-21 |
| 2023-12-31 | 650.00M shares 20-F · filed 2025-04-04 |
| 2023-06-30 | 650.00M shares 6-K · filed 2023-08-14 |
| 2023-03-31 | 650.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 650.00M shares 20-F · filed 2024-03-28 |
| 2022-09-30 | 650.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 650.00M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 650.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 650.00M shares 20-F · filed 2024-03-28 |
| 2021-09-30 | 650.00M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 650.00M shares 10-Q · filed 2021-08-13 |
| 2021-03-31 | 650.00M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 500.00M shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 500.00M shares 10-Q · filed 2020-11-16 |
| 2020-06-30 | 500.00M shares 10-Q · filed 2020-08-14 |
| 2020-03-31 | 100.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 100.00M shares 10-K · filed 2021-03-09 |
| 2018-12-31 | 100.00M shares 10-K · filed 2020-03-17 |
| 2018-06-30 | 30.00M shares 10-K · filed 2021-03-09 |